Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000610959 | SCV000728701 | benign | not specified | 2017-11-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001521965 | SCV001731406 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001584428 | SCV001821600 | benign | Hearing loss, autosomal dominant 37 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001584427 | SCV001821601 | benign | Fibrochondrogenesis 1 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001584426 | SCV001821602 | benign | Marshall syndrome | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001584425 | SCV001821603 | benign | Stickler syndrome type 2 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Molecular Genetics, |
RCV001584425 | SCV004812794 | benign | Stickler syndrome type 2 | 2023-05-04 | criteria provided, single submitter | clinical testing | East Asian population allele frequency is 51.89% (rs34228277, 7250/12548 alleles, 1028 homozygotes in gnomAD v2.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.1.0, this variant is classified as BENIGN. Following criteria are met: BA1 |